US.MDT · Medtronic

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.461805167207247,
        "turnoverUsdM": 587.4264717099999,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.MDT",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 85.0078,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 0.5,
        "macd_score": 3,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 4.9,
      "take_profit_price": 94.0103,
      "target_multiplier": 1.9,
      "technical_strength": 1.65,
      "take_profit_percent": 5.1
    },
    "positionPoints": 1.6,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 4.923610334414494,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 84.4,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 59.4,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 25
  },
  "market": {
    "ma20": 84.519,
    "ma50": 81.9582,
    "close": 89.41,
    "prevClose": 87.16,
    "avgVolume20": 7174702,
    "volumeRatio": 0.92,
    "changePercent": 2.58
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 25,
    "details": {
      "ret_5d": 0.03149515459160113,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 25,
      "vcp_bonus": 0,
      "vol_ratio": 0.9266015180961461,
      "ret_points": 8,
      "vol_points": 0,
      "range_ratio": 1.3011045059553021,
      "volat_points": 2,
      "day_range_pct": 0.030589419528016994,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 8,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": true,
      "return_window_days": 5,
      "first_breakout_bonus": 2,
      "breakout_quality_points": 2
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 84.4,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.6,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 72,
        "contribution": 3.6
      },
      {
        "raw": 11.6,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 58,
        "contribution": 11.6
      },
      {
        "raw": 9.6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 64,
        "contribution": 9.6
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.4,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 74,
        "contribution": 7.4
      },
      {
        "raw": 21.2,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 70.67,
        "contribution": 21.2
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 59.4,
    "details": [
      "基本面分析總分: 3.6/5分",
      "資金流分析總分: 11.6/20分",
      "市場環境分析總分: 9.6/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.4/10分",
      "技術信號分析總分: 21.2/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.6,
      "資金流": 11.6,
      "市場環境": 9.6,
      "情緒分析": 4,
      "技術信號": 21.2,
      "風險管理": 7.4
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "良好",
        "items": {
          "pbPoints": 0.5,
          "pePoints": 0.4,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.4,
          "marginPoints": 0.4,
          "turnoverUsdM": 587.4264717099999,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0.5,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 3.2,
          "obvPoints": 1.6,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.MDT",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 14.9
            }
          },
          "trend": {
            "score": 3.4,
            "details": {
              "qqq": {
                "ma20": 700.7959967,
                "ma50": 714.2728007200001,
                "name": "QQQ",
                "close": 720.87,
                "points": 1.4
              },
              "spy": {
                "ma20": 751.3655031,
                "ma50": 747.5576037400001,
                "name": "SPY",
                "close": 773.030029,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.461805167207247,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 3.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 2,
              "sentimentScoreRaw": 0.6
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141180273,
                "url": "https://finnhub.io/api/news?id=a7e94ce15d383bb683ec1478e8020997e1ab08a713b33adfb4fd3f95cd9f1fd9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "In the closing of the recent trading day, Medtronic (MDT) stood at $89.41, denoting a +2.58% move from the preceding trading day.",
                "category": "company",
                "datetime": 1786398302,
                "headline": "Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know"
              },
              {
                "id": 141170063,
                "url": "https://finnhub.io/api/news?id=b59c6899256f8c262f2bad2e8bc51761dd316b9a38d46a04f39c60357d27744d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "UBS upgraded Medtronic (NYSE:MDT) to a Buy from Neutral today, telling investors in a research note that a “turnaround” is underway at the company. The upgrade raises an important question for investors: Is Medtronic finally returning to sustainable growth after years of underperformance, or is it too early to call the turnaround complete? Bull case […]",
                "category": "company",
                "datetime": 1786319039,
                "headline": "Is Medtronic (MDT) Becoming a Turnaround Story?"
              },
              {
                "id": 141155608,
                "url": "https://finnhub.io/api/news?id=504dee045ca8c8d4d77b4b4cb466748569903edaffb93b33168585f875494b3a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (NYSE:MDT) receives expanded CE Mark indication for its Affera Mapping and Ablation System and Sphere-9 Catheter for ventricular arrhythmia treatment. The Sphere-9 catheter also holds a Breakthrough Device Designation from the U.S. FDA, which highlights its potential clinical impact. This broader regulatory progress could influence Medtronic's position in cardiac arrhythmia care across international markets. As cardiac care technology evolves and Medtronic advances in arrhythmia...",
                "category": "company",
                "datetime": 1786154950,
                "headline": "Medtronic (MDT) Wins Expanded CE Mark For Affera System In Ventricular Arrhythmias"
              },
              {
                "id": 141124345,
                "url": "https://finnhub.io/api/news?id=01d461b4e296a37d43a34864c8519c4769d0ab678678bb3ade4ed62b2051b2d6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "The medical device maker still has a bright future.",
                "category": "company",
                "datetime": 1785946920,
                "headline": "I'm Calling It: Medtronic (MDT) Will Soar 40% by the End of 2026"
              },
              {
                "id": 141104295,
                "url": "https://finnhub.io/api/news?id=8b3d98b3f73e86c23bd24e4dccac5e9857070b5b85f0382714ce09cea10f79b9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "The latest trading day saw Medtronic (MDT) settling at $86.68, representing a +1.51% change from its previous close.",
                "category": "company",
                "datetime": 1785793501,
                "headline": "Medtronic (MDT) Laps the Stock Market: Here's Why"
              },
              {
                "id": 141081608,
                "url": "https://finnhub.io/api/news?id=3af196ab8e1c829b93cb789485e43d768751c4a769284d7097f2ae2a154268f4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Intuitive Surgical (NASDAQ:ISRG) beat both top- and bottom-line consensus estimates in its fiscal Q2 2026 results, with revenue for the quarter growing 19% to $2.89 billion and adjusted EPS reaching $2.80, exceeding expectations by $0.30. However, the stock declined as investors focused on concerns surrounding slowing domestic procedure growth. Medtronic (NYSE:MDT), meanwhile, continued its turnaround […]",
                "category": "company",
                "datetime": 1785525993,
                "headline": "Intuitive Surgical (ISRG) vs. Medtronic (MDT): Which MedTech Stock Looks Better Positioned for Growth?"
              },
              {
                "id": 141078052,
                "url": "https://finnhub.io/api/news?id=26b6897c36432dbd9e3a55f39e084cc0ea36696565ba3bc9472ec916d8293110",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "In late July 2026, Medtronic voluntarily initiated a Class II recall of specific lots of its DLP One-Piece Pediatric Arterial Cannula after two complaints revealed loose foreign material with trace blood, affecting worldwide distribution including several U.S. states. Around the same time, Medtronic led a US$37.00 million Series C funding round for CoreMap to advance electrophysiology mapping for atrial fibrillation, underscoring how quality-control setbacks can coexist with efforts to...",
                "category": "company",
                "datetime": 1785499720,
                "headline": "Is Medtronic’s Cannula Recall and CoreMap Investment Altering The Investment Case For Medtronic (MDT)?"
              },
              {
                "id": 141066849,
                "url": "https://finnhub.io/api/news?id=53fbe8fa89cfcd59e281631d3b1a37a6a3ad140f9fb30f0a2b0a5c306be7ab4e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (MDT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
                "category": "company",
                "datetime": 1785416406,
                "headline": "Medtronic PLC (MDT) Is a Trending Stock: Facts to Know Before Betting on It"
              }
            ],
            "raw_source": [
              {
                "id": 141183707,
                "url": "https://finnhub.io/api/news?id=ab0b084a3da83dbf522e95924a06dfe2aee0bb0e46425b5469a1783b0a5b9f5e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Pulsed Field Ablation Market Pulsed Field Ablation Market Dublin, Aug. 11, 2026 (GLOBE NEWSWIRE) -- The \"Pulsed Field Ablation Market by Therapeutic Area, Product Components, Application Area, Source of Ablation, Key Geographical Regions, and Sales Forecast of Leading Players - Trends and Forecast till 2035\" has been added to ResearchAndMarkets.com's offering. The global pulsed field ablation market is projected to expand from approximately USD 3.2 billion in 2026 to USD 14.6 billion by 2035, re",
                "category": "company",
                "datetime": 1786439100,
                "headline": "Pulsed Field Ablation Global Market Report 2026 Now Available - Profiles Boston Scientific, Medtronic, Biosense Webster, and 15 Other Players"
              },
              {
                "id": 141180251,
                "url": "https://finnhub.io/api/news?id=a6bb69a3c64c468bcfefa3069e4028a9ceb2012aea27cea11f4e1eb25f828234",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Abbott Laboratories (NYSE:ABT) and Medtronic (NYSE:MDT) are both prominent names in the Medtech space. Abbott Laboratories (NYSE:ABT) delivered strong fiscal Q2 2026 results, beating quarterly estimates and raising its annual profit forecast as robust demand for its cancer diagnostics and medical devices businesses helped ease investor concerns surrounding procedure volumes. Medtronic (NYSE:MDT), meanwhile, continued to […]",
                "category": "company",
                "datetime": 1786401985,
                "headline": "Abbott vs. Medtronic: Is Consistent Growth Better Than a Turnaround Story?"
              },
              {
                "id": 141180197,
                "url": "https://finnhub.io/api/news?id=e1475054062b34cd1e579db6e30f51d53ff66584d8bd4898bca58b1dd1f00b49",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Johnson & Johnson (NYSE:JNJ) delivered another strong quarter in fiscal Q2 2026, with reported sales increasing 6.6% year over year to $25.31 billion and surpassing analysts’ average estimate of around $25.05 billion. Adjusted earnings per share reached $2.90, also exceeding estimates of $2.85. The healthcare giant raised its full-year outlook and said it remains on […]",
                "category": "company",
                "datetime": 1786401417,
                "headline": "Johnson & Johnson vs. Medtronic: Which Healthcare Stock Is Better Positioned After Earnings?"
              },
              {
                "id": 141180273,
                "url": "https://finnhub.io/api/news?id=a7e94ce15d383bb683ec1478e8020997e1ab08a713b33adfb4fd3f95cd9f1fd9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "In the closing of the recent trading day, Medtronic (MDT) stood at $89.41, denoting a +2.58% move from the preceding trading day.",
                "category": "company",
                "datetime": 1786398302,
                "headline": "Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know"
              },
              {
                "id": 141178957,
                "url": "https://finnhub.io/api/news?id=c3da4444232be2ab8058c91b5377f8baa667d31154ba1730801ed19366e8434a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "The BACKBEAT global pivotal trial (“BACKBEAT Trial”), conducted in collaboration with Medtronic, is on track to reach its target of 284 evaluable randomized patients by end of Q3 2026, with primary data presentation targeted for Q2 2027, assuming those endpoints are met.Virtue pivotal trial is advancing with further site activations and patient enrollments. $110 million cash balance provides projected runway into Q4 2027 and through key upcoming milestones, following $35 million in strategic cap",
                "category": "company",
                "datetime": 1786392720,
                "headline": "Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates"
              },
              {
                "id": 141177545,
                "url": "https://finnhub.io/api/news?id=900a27fb3b4f315b53cc3d81f4180c5a0e7c3de6b57840523330bdfb92cad3d6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Two stalled franchises forced the guidance cut, and they sit outside the three quarters of revenue management still expects to grow at its long-run pace, with the shares now near the bottom of their decade on sales.",
                "category": "company",
                "datetime": 1786385693,
                "headline": "Boston Scientific Stock Is Priced As If WATCHMAN Were The Whole Company"
              },
              {
                "id": 141175263,
                "url": "https://finnhub.io/api/news?id=651fb21e318bc41ddae43d10d7c2453b96582a7b566b22793ffdf458b66e5630",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "ISRG's premium valuation faces scrutiny as strong Q2 growth, higher margins and expanding robotic platforms support its 2026 outlook.",
                "category": "company",
                "datetime": 1786372920,
                "headline": "ISRG Trades at a Premium P/E: Buy, Sell or Hold the Stock Now?"
              },
              {
                "id": 141180274,
                "url": "https://finnhub.io/api/news?id=a28d6b3f8e6ecbe8fe73f51cad60f26f959f273774b259701a2ac25c06f48a1d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "According to MarketsandMarkets™, the Ventilators Market is projected to reach USD 3.10 billion by 2031 from USD 2.49 billion in 2026, at a CAGR of 4.4% during the forecast period.",
                "category": "company",
                "datetime": 1786370460,
                "headline": "Ventilators Market worth $3.10 billion by 2031 - Exclusive Report by MarketsandMarkets™"
              },
              {
                "id": 141174297,
                "url": "https://finnhub.io/api/news?id=69abc7bda0fef2cc41514d6b8a86bc01b40e4cb7b2b108f5ac878016d42a3aad",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Four Dividend Aristocrats were flagged as stealth growth plays a year ago, and the results cut sharply in two directions. See which names delivered and which stumbled, plus three fresh picks where the dividend coverage story is quietly getting stronger.",
                "category": "company",
                "datetime": 1786369539,
                "headline": "We Said These 4 Dividend Aristocrats Could Soar. Here’s How They Did, Plus 3 New Picks."
              },
              {
                "id": 141174390,
                "url": "https://finnhub.io/api/news?id=30a8d85dad9afaa387e048a0b2d872310dca04c5670c0bbbdc9e372c0e13a3a8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "VAREX IMAGING (VREX) delivered earnings and revenue surprises of +40.91% and -2.80%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1786364105,
                "headline": "VAREX IMAGING (VREX) Q3 Earnings Beat Estimates"
              },
              {
                "id": 141174970,
                "url": "https://finnhub.io/api/news?id=710ae30f715dbe8a1db9a8a367dff6667296222dcfa6daaef1ed32eccf51a1aa",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1622428628/image_1622428628.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MDT",
                "summary": "Medtronic earns a Buy rating with income, growth, and value. Click for more on MDT stock.",
                "category": "company",
                "datetime": 1786361348,
                "headline": "Medtronic: Buy This Undervalued Dividend Aristocrat Before The Market Catches On"
              },
              {
                "id": 141170063,
                "url": "https://finnhub.io/api/news?id=b59c6899256f8c262f2bad2e8bc51761dd316b9a38d46a04f39c60357d27744d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "UBS upgraded Medtronic (NYSE:MDT) to a Buy from Neutral today, telling investors in a research note that a “turnaround” is underway at the company. The upgrade raises an important question for investors: Is Medtronic finally returning to sustainable growth after years of underperformance, or is it too early to call the turnaround complete? Bull case […]",
                "category": "company",
                "datetime": 1786319039,
                "headline": "Is Medtronic (MDT) Becoming a Turnaround Story?"
              },
              {
                "id": 141161586,
                "url": "https://finnhub.io/api/news?id=3c5b80e1d6367d6c3134d7ed2dbab5b1d0b0d318b656d268af63da5b1b6a3785",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "They are going through a rough patch, but it's too early to give up on them.",
                "category": "company",
                "datetime": 1786224000,
                "headline": "Medtronic vs. Intuitive Surgical: Which MedTech Stock Is the Better Buy Right Now?"
              },
              {
                "id": 141159772,
                "url": "https://finnhub.io/api/news?id=e886dd9a371b1193cc20166cfff1c8eb46fbec57659ce18470ef42e953cbf51c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Intuitive Surgical is a leader in the surgical robotics space, with a large installed base and strong recurring revenues.",
                "category": "company",
                "datetime": 1786206900,
                "headline": "Competition Is Heating Up, but Here's Why Intuitive Surgical Might Still Be the Smartest Bet in MedTech"
              },
              {
                "id": 141157889,
                "url": "https://finnhub.io/api/news?id=c0352c42a3ef8e0c8c3348709ded75f12dd8c95242bad3e9a9ae7d785e605ddc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Intuitive Surgical has shed a third of its value while its robotic surgery peers barely flinched, and Wall Street's most bullish analyst sees an outcome that would leave anyone who sold near the bottom regretting it.",
                "category": "company",
                "datetime": 1786187149,
                "headline": "The Robotic Surgery Leader: Intuitive Surgical Slides Further But One Wall Street Bull Pegs Returns at 85%"
              },
              {
                "id": 141155608,
                "url": "https://finnhub.io/api/news?id=504dee045ca8c8d4d77b4b4cb466748569903edaffb93b33168585f875494b3a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (NYSE:MDT) receives expanded CE Mark indication for its Affera Mapping and Ablation System and Sphere-9 Catheter for ventricular arrhythmia treatment. The Sphere-9 catheter also holds a Breakthrough Device Designation from the U.S. FDA, which highlights its potential clinical impact. This broader regulatory progress could influence Medtronic's position in cardiac arrhythmia care across international markets. As cardiac care technology evolves and Medtronic advances in arrhythmia...",
                "category": "company",
                "datetime": 1786154950,
                "headline": "Medtronic (MDT) Wins Expanded CE Mark For Affera System In Ventricular Arrhythmias"
              },
              {
                "id": 141148238,
                "url": "https://finnhub.io/api/news?id=696898ab38e7e978feac56e8302e491bdce67d7232a6e2cc9827379a8899fa7d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Older ablation approaches for ventricular tachycardia have been suboptimal, Medtronic said. The company plans to bring a more effective treatment for the life-threatening heart condition.",
                "category": "company",
                "datetime": 1786099813,
                "headline": "Medtronic gets CE mark for ablation to treat ventricular tachycardia"
              },
              {
                "id": 141140621,
                "url": "https://finnhub.io/api/news?id=5a6f32da6a1cb9c37b31b91ca6a1ad5265594dafcc9d698d08129586c01086e8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "AngioDynamics' fiscal 2027 outlook hinges on Med Tech growth offsetting flat device sales as tariffs, spending and losses pressure margins.",
                "category": "company",
                "datetime": 1786039980,
                "headline": "ANGO's FY27 Guidance Puts Med Tech Growth and Tariff Risks in Focus"
              },
              {
                "id": 141140622,
                "url": "https://finnhub.io/api/news?id=0e1174f6ba0b007d3383ae931962246e360ffe9b2d45e970b684a4bbf165f2e2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "AngioDynamics' 33.5% three-month rally rests on Med Tech growth, but valuation, tariffs and negative earnings keep execution risks high.",
                "category": "company",
                "datetime": 1786039620,
                "headline": "ANGO Jumps 33.5% in 3 Months: Can the Rally Keep Going?"
              },
              {
                "id": 141135592,
                "url": "https://finnhub.io/api/news?id=92ae03b3ffe923b83fa48c0520ff02a53f0c2a06998836ddecc4e965344e5a0e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Cresco Labs Inc. (CRLBF) delivered earnings and revenue surprises of +300.00% and +4.41%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1786024204,
                "headline": "Cresco Labs Inc. (CRLBF) Q2 Earnings and Revenues Top Estimates"
              },
              {
                "id": 141133319,
                "url": "https://finnhub.io/api/news?id=5315b76a855de4fc9d0ed21c2127b088418baf12e390ef54000ec0108da7b8bd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced an expanded CE Mark indication for the Affera™ Mapping and Ablation System with Sphere-9™ Catheter to treat ventricular arrhythmias, including ventricular tachycardia (VT) and premature ventricular complexes (PVCs). The Sphere-9 catheter is the first all-in-one mapping and ablation, large-tip focal, dual-energy catheter CE marked for ventricular ablation.",
                "category": "company",
                "datetime": 1786014000,
                "headline": "Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias"
              },
              {
                "id": 141133788,
                "url": "https://finnhub.io/api/news?id=ccfe548320a03015e958d00e621de8931f2aaa56083a349960ae1c56ad152b8d",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1359351391/image_1359351391.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MDT",
                "summary": "Discover Seeking Alpha’s July spotlight on top new analysts and highest‑conviction stock ideas—from Strong Sell to Strong Buy.",
                "category": "company",
                "datetime": 1786006800,
                "headline": "Stock Picks From Seeking Alpha's July 2026 New Analysts"
              },
              {
                "id": 141136241,
                "url": "https://finnhub.io/api/news?id=c600932b4971173bb16f0756f40ed20b5aa0c08fff5841197591b3834eb8740d",
                "image": "",
                "source": "Benzinga",
                "related": "MDT",
                "summary": "Additionally, in recognition of the critical unmet need for ventricular arrhythmia treatments, the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation for the Sphere-9 catheter for the",
                "category": "company",
                "datetime": 1786000955,
                "headline": "Medtronic Announces Expanded CE Mark Indication For Its Affera Mapping And Ablation System With Sphere-9 Catheter To Treat Ventricular Arrhythmias, Including Ventricular Tachycardia And Premature Ventricular Complexes"
              },
              {
                "id": 141124345,
                "url": "https://finnhub.io/api/news?id=01d461b4e296a37d43a34864c8519c4769d0ab678678bb3ade4ed62b2051b2d6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "The medical device maker still has a bright future.",
                "category": "company",
                "datetime": 1785946920,
                "headline": "I'm Calling It: Medtronic (MDT) Will Soar 40% by the End of 2026"
              },
              {
                "id": 141124190,
                "url": "https://finnhub.io/api/news?id=ef66cdca1edae98df18b0c5ebc62b1879e71fd41b3c066690822a1c935a99bcb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Boston Scientific's cheaper valuation offers upside, but weaker guidance, share losses, higher debt and delayed catalysts favor patience.",
                "category": "company",
                "datetime": 1785945060,
                "headline": "Should Investors Buy Boston Scientific Stock Despite Near-Term Risks?"
              },
              {
                "id": 141119285,
                "url": "https://finnhub.io/api/news?id=a6584adc52960266f67068928cb09319d45896a354b71ff148bac38924f3418f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "From Beneath Ancient Rome to the Future of the Power Grid: a new mini-documentary series by Nicely Done Productions reveals the hidden infrastructure of modern life, hosted on National Geographic's global digital platform.",
                "category": "company",
                "datetime": 1785909900,
                "headline": "New Series Reveals the Hidden Infrastructure of Modern Life"
              },
              {
                "id": 141113185,
                "url": "https://finnhub.io/api/news?id=ffe8f821463a343289a11f64068bcee41cc91dca55356f4a3d50ffb074e8f0f3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "The healthcare giant showered its owners with cash, yet the stock fell behind. Here is the accounting of what investors actually got and what the trade-off cost them.",
                "category": "company",
                "datetime": 1785871390,
                "headline": "The $85 Billion Consolation Prize For JNJ Shareholders"
              },
              {
                "id": 141111746,
                "url": "https://finnhub.io/api/news?id=1650714c92a4e802d67fbd78b6759dc56475df054016e3f7f1590d1f74b9c68f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "These stocks pay between 3.4% and 6.1% in dividends.",
                "category": "company",
                "datetime": 1785858783,
                "headline": "Retirees: 3 High-Yielding Dividend Stocks to Buy for Long-Term Stability and Recurring Cash Flow"
              },
              {
                "id": 141114695,
                "url": "https://finnhub.io/api/news?id=635293fb87338e3d3b3b31efba9e4826149fbb239f3fac9492c31a348c20cf33",
                "image": "",
                "source": "Benzinga",
                "related": "MDT",
                "summary": "- Reuters Citing Attorney",
                "category": "company",
                "datetime": 1785851568,
                "headline": "U.S. Jury Says Medtronic Owes $88M In First Case To Go To Trial Over Covidien's Hernia Mesh"
              },
              {
                "id": 141107182,
                "url": "https://finnhub.io/api/news?id=c7afd9143e3f8ba23a4dfea921d0f7e6524a5e62d4051e4471a8af973ae51f02",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Learn the warning signs of stroke and how new technologies are transforming neurovascular care.​ NORTHAMPTON, MA / ACCESS Newswire / August 4, 2026 / Medtronic - ​​Your brain controls everything from how you move and speak to how you think, remember, ...",
                "category": "company",
                "datetime": 1785836100,
                "headline": "What Everyone Should Know About Brain Health and Stroke"
              },
              {
                "id": 141104960,
                "url": "https://finnhub.io/api/news?id=d01aa04ea2d43f3e2f4f1f4c7db2809846644cd559deb127613fec1f30e8d705",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Ainex Corporation (CEO David Lee; hereinafter \"Ainex\"), a medical AI company specializing in gastrointestinal endoscopy, announced that it has signed an agreement with Singapore's National University Hospital (NUH) to supply its real-time AI-assisted diagnostic software for upper and lower gastrointestinal endoscopy, Endoscopy as AI-powered Device (hereinafter \"ENAD\"). Ainex will also expand its joint clinical research partnership with NUH to further advance ENAD's AI algorithms and enhance its",
                "category": "company",
                "datetime": 1785801600,
                "headline": "Ainex's ENAD Chosen for Singapore's National University Hospital After Global Competition"
              },
              {
                "id": 141104295,
                "url": "https://finnhub.io/api/news?id=8b3d98b3f73e86c23bd24e4dccac5e9857070b5b85f0382714ce09cea10f79b9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "The latest trading day saw Medtronic (MDT) settling at $86.68, representing a +1.51% change from its previous close.",
                "category": "company",
                "datetime": 1785793501,
                "headline": "Medtronic (MDT) Laps the Stock Market: Here's Why"
              },
              {
                "id": 141100908,
                "url": "https://finnhub.io/api/news?id=e4fb0ac9dbc8e8ca0df683b11a60daf97614e17b5f0f85789c3c86e16fe8e491",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Abbott Laboratories has shed billions in market value this year while the broader market climbed, yet one analyst on Wall Street sees a dramatically different story unfolding beneath the surface of the company's bruised financials.",
                "category": "company",
                "datetime": 1785771878,
                "headline": "Abbott Laboratories Lost 16% This Year: One Analyst Sees 35% Gains for the Healthcare Giant"
              },
              {
                "id": 141081608,
                "url": "https://finnhub.io/api/news?id=3af196ab8e1c829b93cb789485e43d768751c4a769284d7097f2ae2a154268f4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Intuitive Surgical (NASDAQ:ISRG) beat both top- and bottom-line consensus estimates in its fiscal Q2 2026 results, with revenue for the quarter growing 19% to $2.89 billion and adjusted EPS reaching $2.80, exceeding expectations by $0.30. However, the stock declined as investors focused on concerns surrounding slowing domestic procedure growth. Medtronic (NYSE:MDT), meanwhile, continued its turnaround […]",
                "category": "company",
                "datetime": 1785525993,
                "headline": "Intuitive Surgical (ISRG) vs. Medtronic (MDT): Which MedTech Stock Looks Better Positioned for Growth?"
              },
              {
                "id": 141078052,
                "url": "https://finnhub.io/api/news?id=26b6897c36432dbd9e3a55f39e084cc0ea36696565ba3bc9472ec916d8293110",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "In late July 2026, Medtronic voluntarily initiated a Class II recall of specific lots of its DLP One-Piece Pediatric Arterial Cannula after two complaints revealed loose foreign material with trace blood, affecting worldwide distribution including several U.S. states. Around the same time, Medtronic led a US$37.00 million Series C funding round for CoreMap to advance electrophysiology mapping for atrial fibrillation, underscoring how quality-control setbacks can coexist with efforts to...",
                "category": "company",
                "datetime": 1785499720,
                "headline": "Is Medtronic’s Cannula Recall and CoreMap Investment Altering The Investment Case For Medtronic (MDT)?"
              },
              {
                "id": 141066849,
                "url": "https://finnhub.io/api/news?id=53fbe8fa89cfcd59e281631d3b1a37a6a3ad140f9fb30f0a2b0a5c306be7ab4e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (MDT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
                "category": "company",
                "datetime": 1785416406,
                "headline": "Medtronic PLC (MDT) Is a Trending Stock: Facts to Know Before Betting on It"
              },
              {
                "id": 141064640,
                "url": "https://finnhub.io/api/news?id=3fbe0056e90fefb5a1a29ed818078c66c924df0cd1d8f3e2e23fd09199211876",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "CoreMap's latest fundraise almost doubles the privately held company's funds raised since its founding in 2016.",
                "category": "company",
                "datetime": 1785411591,
                "headline": "CoreMap raises $37m in Medtronic-led financing round"
              },
              {
                "id": 141066850,
                "url": "https://finnhub.io/api/news?id=d8386d642b0eddcdbee41181391f7dca81eb822296f7d5732b6902b869928d78",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic has backed CoreMap to address a critical unmet need in atrial fibrillation treatment.",
                "category": "company",
                "datetime": 1785394861,
                "headline": "Medtronic leads $37M investment in ablation mapping startup CoreMap"
              },
              {
                "id": 141058511,
                "url": "https://finnhub.io/api/news?id=6ba38d0bf0ecc6b13c0f86531e8167510e0f75b71b00d6babd0cb13f6cc9b37a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Align Technology will add three new independent directors to its board and launch a review of its operations ‌following talks with activist investor Elliott Investment Management, the company said ‌on Wednesday.  The three new board ​members, who have not yet been named, will be chosen for their expertise in healthcare technology, medical devices, global operations, and scaling high-growth businesses.  Elliott, one of Wall Street's most prominent activist investors, has increasingly turned its attention to ‌healthcare companies over the past ⁠year, often pushing for board representation and strategic reviews to boost performance.",
                "category": "company",
                "datetime": 1785358361,
                "headline": "Align Technology to add directors, launch review after deal with Elliott"
              },
              {
                "id": 141059588,
                "url": "https://finnhub.io/api/news?id=67311e2187c8daa5f97909344e3c76b99fbde905a77e989bccdfea2563d55757",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2225310528/image_2225310528.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MDT",
                "summary": "NOBL beats SPY YTD in 2026; explore 25 undervalued Dividend Aristocrats with 10%+ projected returns and fresh dividend hikes—see the list now.",
                "category": "company",
                "datetime": 1785354040,
                "headline": "Best Dividend Aristocrats For August 2026"
              },
              {
                "id": 141054230,
                "url": "https://finnhub.io/api/news?id=2d8e25a88d9a028918c7e979b91906974b96c24259987bf65e557c41094a6c15",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic could finally be on the cusp of a long-awaited turnaround.",
                "category": "company",
                "datetime": 1785337499,
                "headline": "This Stock Is Knocking on the Door of the Dividend Kings -- and Wall Street Thinks It Has Room to Run"
              },
              {
                "id": 141053857,
                "url": "https://finnhub.io/api/news?id=4a864f6079fb25b319e4132641b5ae6284a439e09c61e9a949fef8ca5fcda97f",
                "image": "",
                "source": "Fintel",
                "related": "MDT",
                "summary": "",
                "category": "company",
                "datetime": 1785336313,
                "headline": "UBS Upgrades Medtronic (MDT)"
              },
              {
                "id": 141053281,
                "url": "https://finnhub.io/api/news?id=c8e5fec55ce152c1ae6354957dc3bbd151dcbca6a9ba72d322bff0b1a932d8bb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "In the world of robotic surgery, one company is both the undisputed leader and the most expensive name on the shelf, forcing investors to ask if operational brilliance is worth the high price of admission.",
                "category": "company",
                "datetime": 1785332790,
                "headline": "The Best House On The Block Costs The Most: ISRG"
              },
              {
                "id": 141053143,
                "url": "https://finnhub.io/api/news?id=2d7f25bc4b6a8edb59db419cba6b9158951e10cdeea81e98bc2d5ad143237d8c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "United States Surgical pioneered the development of surgical staples that put the firm at the forefront of the stock market.",
                "category": "company",
                "datetime": 1785326440,
                "headline": "United States Surgical: How To Find & Own America's Greatest Opportunities"
              },
              {
                "id": 141047303,
                "url": "https://finnhub.io/api/news?id=556426890a3fac26e5447912eb362cc02010df281b0dcb32f90c4409a7a36c9e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Johnson & Johnson stock's oncology engine and its steady guidance raises were on the record quarters before the price moved.",
                "category": "company",
                "datetime": 1785271965,
                "headline": "What Johnson & Johnson Stock Told You Before It Surged"
              },
              {
                "id": 141046228,
                "url": "https://finnhub.io/api/news?id=366bb3ca8848ba5152308566799255dd9d7dc151bab93b311925e61a56141cda",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Digital Transformation in Healthcare Market size & share revenue was valued at approximately USD 72.3 Billion in 2025 and is expected to reach USD 81.7 Billion in 2026 and is expected to reach around USD 270.9 Billion by 2035, at a CAGR of 14.13% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Oracle Hea",
                "category": "company",
                "datetime": 1785267000,
                "headline": "Global Digital Transformation in Healthcare Market Size/Share Worth USD 270.9 Billion by 2035 at a 14.13% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)"
              },
              {
                "id": 141055444,
                "url": "https://finnhub.io/api/news?id=a52dbb39746a18f9436b93f08d249dd13b6fad6c197451e6c2d1cef15420ae28",
                "image": "",
                "source": "Benzinga",
                "related": "MDT",
                "summary": "UBS  analyst Priya Sachdeva   upgrades Medtronic (NYSE:MDT) from Neutral to Buy and raises the price target from $85 to $100.",
                "category": "company",
                "datetime": 1785251550,
                "headline": "UBS Upgrades Medtronic to Buy, Raises Price Target to $100"
              },
              {
                "id": 141042348,
                "url": "https://finnhub.io/api/news?id=56f2f285ff59a3a37ef0ce4aefbadc33ee3bcdb7f56f7c7e94741a06e3cf8529",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Intuitive Surgical (NASDAQ:ISRG) trades at $356.83, while the average Wall Street price target sits at $484.40. That leaves roughly a 36% gap between current price and Street consensus. Intuitive builds the da Vinci robotic surgery platform and the Ion lung biopsy system, dominating soft tissue surgical robotics. Wall Street has debated whether that moat holds ... Intuitive Surgical Fell 37% to $355 With This Wall Street Pro Is Calling for $685",
                "category": "company",
                "datetime": 1785246435,
                "headline": "Intuitive Surgical Fell 37% to $355 With This Wall Street Pro Is Calling for $685"
              },
              {
                "id": 141043715,
                "url": "https://finnhub.io/api/news?id=c1ea1eb6a2951f004125dc530ce0cb2e9c935f6d2ff11d03b16788839719982a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "ABT is expanding across diabetes care, oncology diagnostics and heart devices, with new launches and acquisitions creating multiple growth paths to watch.",
                "category": "company",
                "datetime": 1785245340,
                "headline": "Abbott Rides Key Diabetes, Oncology and Heart Care Innovation Trends"
              },
              {
                "id": 141042564,
                "url": "https://finnhub.io/api/news?id=5ff9fcd840a0108c3e0a257968ab637b575a91a691813218bd86fb06c7474223",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "TXN posted strong Q2 2026 results as AI-driven demand, expanding margins and upbeat guidance strengthen its momentum outlook.",
                "category": "company",
                "datetime": 1785240060,
                "headline": "Buy Texas Instruments as a Momentum Play After Solid Q2 2026 Earnings"
              },
              {
                "id": 141041757,
                "url": "https://finnhub.io/api/news?id=e608a003141f5e728800fd2bcdd8587566b862645fcbc91a95de09a83cfd0975",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Cloud-based AI algorithm supports implantable cardiac monitors from all major manufacturers, reducing false-positive alerts by up to 76% while maintaining high sensitivity for true events CAMBRIDGE, Mass., July 28, 2026 (GLOBE NEWSWIRE) -- Implicity, a leader in remote patient monitoring and cardiac data management solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its next-generation ILR ECG Analyzer, marking Implicity's third FDA cleara",
                "category": "company",
                "datetime": 1785239100,
                "headline": "Implicity’s Next-Generation ILR ECG Analyzer Earns FDA Clearance"
              },
              {
                "id": 141044506,
                "url": "https://finnhub.io/api/news?id=b5212a9cffc22f69af429a94a00b73834871dd744452ce9c9e0c1171347e5069",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/28/Healthcare-stocks.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MDT",
                "summary": "In times of market turbulence, dividend-yielding stocks are popular for investors. Check out analyst ratings for high-yielding stocks and recent news on Bristol-Myers Squibb, GSK, and Medtronic PLC on Benzinga's Analyst Stock Ratings page.Investors turn to dividend-yielding stocks in turbulent markets. Check out analyst ratings and news for high-yielding stocks on Benzinga's Analyst Stock Ratings page.",
                "category": "company",
                "datetime": 1785224299,
                "headline": "Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields"
              },
              {
                "id": 141040706,
                "url": "https://finnhub.io/api/news?id=884f19b4e86c5f026b215a61a3daca1d5c2d2bd50fc36f3770f98f6ee1386695",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (MDT) is in focus after a voluntary Class II recall of its DLP One-Piece Pediatric Arterial Cannula, following two complaints about loose foreign material containing trace levels of blood. See our latest analysis for Medtronic. Despite the recall headlines, Medtronic’s recent 30-day share price return of 4.00% and 90-day share price return of 2.83% sit against a year-to-date share price decline of 12.32%. The 3-year total shareholder return of 5.91% contrasts with a 5-year total...",
                "category": "company",
                "datetime": 1785222570,
                "headline": "Is Medtronic (MDT) Fairly Valued After Its Pediatric Cannula Recall?"
              },
              {
                "id": 141040707,
                "url": "https://finnhub.io/api/news?id=99448b1eb689f9fb453eea7e1e3023961a969f144de175499acfbbc37c1ddb76",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (NYSE:MDT) has completed its US$650m acquisition of SPR Therapeutics. The company formally launched the ViaVerte system at ASPN 2026, expanding its pain therapy portfolio. The deal adds a non opioid pain management platform to Medtronic’s existing medical device offerings. Medtronic is known for its broad medical device portfolio across cardiology, neurology and surgical care. With the SPR Therapeutics deal and ViaVerte launch, the company is putting more weight behind...",
                "category": "company",
                "datetime": 1785218985,
                "headline": "Medtronic (MDT) Completes $650 Million SPR Deal And Launches ViaVerte"
              },
              {
                "id": 141039668,
                "url": "https://finnhub.io/api/news?id=0361353319a8870517fac2bff2c0a12d20fe65d225e88a60290737f2e4abd8ca",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic stock is coming off a 5 year period where the share price has fallen about 25%, yet current checks suggest the shares sit close to their intrinsic value on a Discounted Cash Flow (DCF) basis and screen as undervalued on earnings multiples. That mix, alongside fresh moves in AI assisted surgery and pain management, leaves investors weighing whether the current price around US$84.22 offers enough compensation for the risks. Over 5 years the share price has declined about 25%, which...",
                "category": "company",
                "datetime": 1785204552,
                "headline": "Medtronic (MDT) Stock May Be Fairly Valued As Shares Sit Near A 5 Year Low"
              },
              {
                "id": 141038209,
                "url": "https://finnhub.io/api/news?id=2bb8c4fb1b536fd9f2a337bc87b71cce228aca8bd9d507577176072a1bca904e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (MDT) closed at $84.22 in the latest trading session, marking a +1.21% move from the prior day.",
                "category": "company",
                "datetime": 1785189003,
                "headline": "Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know"
              },
              {
                "id": 141035129,
                "url": "https://finnhub.io/api/news?id=c92ef4a473af545abf93085c0feb833d345113b7ee6e12a65912c65c41f0d0ff",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "J&J's MedTech growth slowed down in Q2 as Cardiovascular lagged, but new product launches and stronger Vision, Surgery and Orthopedics may lift H2 sales.",
                "category": "company",
                "datetime": 1785167220,
                "headline": "J&J's MedTech Performance Slows in Q2: Will Sales Improve in H2?"
              },
              {
                "id": 141033957,
                "url": "https://finnhub.io/api/news?id=f9c77f2c7a2b30fa8a6e2c19700b09a28d1482789e3ac5a2c0c0cc32cff09d93",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "A steadily shrinking share count and a giant float owed to suppliers are handing owners a bigger slice of the drug distributor each year, even as drug-pricing worries hang over the stock.",
                "category": "company",
                "datetime": 1785160469,
                "headline": "The Buyback Machine Hiding Behind Cardinal Health's Thin Margins"
              },
              {
                "id": 141033911,
                "url": "https://finnhub.io/api/news?id=3609c866b6c1c8cb9e463baa69526262f4a9897a86ea509014ba2e333ed00030",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "ABT's earnings beat and higher profit outlook strengthen its case, but can growth in devices and diagnostics overcome valuation and acquisition concerns?",
                "category": "company",
                "datetime": 1785156060,
                "headline": "Is Abbott Stock Attractive After Its Earnings and Guidance Update?"
              },
              {
                "id": 141032243,
                "url": "https://finnhub.io/api/news?id=2dabf0acd258c992ef894f86a9c9a077827217cddc613923fdb41d1a5288f872",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic formally launched ViaVerte at ASPN 2026, with its $650m acquisition of SPR Therapeutics completing at the meeting’s outset on 16 July.",
                "category": "company",
                "datetime": 1785150951,
                "headline": "Medtronic continues assembly of industry’s “broadest” pain therapy portfolio"
              },
              {
                "id": 141031076,
                "url": "https://finnhub.io/api/news?id=62173fbda2301693a92f3d5da56390b4ea3db8e08c290385b475eabf6e1d5a7b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "The company that used to reassure you with its sheer breadth now leads with a push to dominate oncology, and a holder who bought a diversified compounder should notice the bet has changed shape.",
                "category": "company",
                "datetime": 1785135053,
                "headline": "Johnson & Johnson Now Leads Its Pitch With An Oncology Bet"
              },
              {
                "id": 141016864,
                "url": "https://finnhub.io/api/news?id=02a7054929fccd13b94135fcc42ef9eaf195056dd9ae3898a266d92a88bdf526",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Management's plain health care label has slipped out of the lead, and the business now on a separation clock is the one that finally started working.",
                "category": "company",
                "datetime": 1784989802,
                "headline": "Johnson & Johnson Is Becoming A Narrower Company Than You Bought"
              },
              {
                "id": 141015190,
                "url": "https://finnhub.io/api/news?id=a1740af6ee5bb16e8078372181f62d0df745b3c8a1307681af8f6b4ea8cf6b6d",
                "image": "https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp",
                "source": "ChartMill",
                "related": "MDT",
                "summary": "Medtronic (MDT) appears in a Decent Value screen: cheap valuation, strong profitability, and improving growth outlook for value investors.",
                "category": "company",
                "datetime": 1784974259,
                "headline": "Medtronic (NYSE:MDT): A Value Stock with a Discounted Valuation and Accelerating Growth"
              },
              {
                "id": 141005276,
                "url": "https://finnhub.io/api/news?id=fce891feb90878c9b568365dc8ab8155bd45866a90ca9d2b3a5d6fc1f72863eb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "The robotic surgery leader's shares have pulled back, forcing investors to weigh a solid recovery record against new questions in its most important market.",
                "category": "company",
                "datetime": 1784897252,
                "headline": "Intuitive Surgical Stock Is On Sale, But Is The Growth Story Changing?"
              },
              {
                "id": 141017280,
                "url": "https://finnhub.io/api/news?id=76d2787cc2237b397d2f26adc0684909ea937123a4b2b20124117fe4fa5e2b68",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/24/24-7-2026-111735-thebambooworks-com.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MDT",
                "summary": "The medical robot maker expects to report a profit of 28 million yuan to 40 million yuan for the first half of 2026, reversing years of losses\n\n\n\n\n\n\n\nimage credit: Bamboo Works\n\n\n\nKey Takeaways:\n\n\n\n\nMicroPort MedBot",
                "category": "company",
                "datetime": 1784897088,
                "headline": "MicroPort MedBot To Report First-Ever Profit On Booming Exports"
              },
              {
                "id": 141005373,
                "url": "https://finnhub.io/api/news?id=b36b031e7ee377bc4138167b006d1828b02fd77c1e500f55b43a05f249614da2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Device makers with cash flow yields of 5% to 6% now trade at a 20% to 30% discount to the S&P 500 index.",
                "category": "company",
                "datetime": 1784895900,
                "headline": "6 Medical-Device Stocks to Buy After a Massive Selloff"
              },
              {
                "id": 141003245,
                "url": "https://finnhub.io/api/news?id=2ebd8eda6820cc2c6f0a825f7bed40d44a97ae7a597344157a7a0eb81e98b72d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Device makers with cash flow yields of 5% to 6% now trade at a 20% to 30% discount to the S&P 500 index.",
                "category": "company",
                "datetime": 1784871000,
                "headline": "Medical-Device Stocks Are in the Bargain Bin. 6 to Buy."
              },
              {
                "id": 140997814,
                "url": "https://finnhub.io/api/news?id=24d2e0fc54cab935e274a3e8fcb16db266c3a84f202471884f91fe10684e6523",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": ": Medtronic is set to report Q1 earnings, with analysts expecting high single-digit year-over-year EPS growth.",
                "category": "company",
                "datetime": 1784808273,
                "headline": "Medtronic Earnings Preview: What to Expect"
              },
              {
                "id": 140991917,
                "url": "https://finnhub.io/api/news?id=7ab192dfbf41ef76ac4294c5809430ed4818de2a6746036969d6d7104a33c13e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Implantable Cardiac Fluorine-Free Resins Market size & share revenue was valued at approximately USD 1.52 Billion in 2025 and is expected to reach USD 1.67 Billion in 2026 and is expected to reach around USD 4.26 Billion by 2035, at a CAGR of 10.8% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Covestro",
                "category": "company",
                "datetime": 1784795400,
                "headline": "[Latest] Global Implantable Cardiac Fluorine-Free Resins Market Size/Share Worth USD 4.26 Billion by 2035 at a 10.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate,SWOT Analysis)"
              },
              {
                "id": 140984722,
                "url": "https://finnhub.io/api/news?id=eb4380e4b81ff41df4f41f4d09a834efdf3a51fc5ecc7ebde526712ba4b692b7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Intuitive Surgical's growth rests on da Vinci 5, Ion, SP and digital tools as recurring revenue rises and procedure risks persist.",
                "category": "company",
                "datetime": 1784736300,
                "headline": "ISRG Growth Story Hinges on Da Vinci 5, Ion and Recurring Revenue"
              },
              {
                "id": 140984723,
                "url": "https://finnhub.io/api/news?id=b43dd450ad337f594f3885cf44a2dfe69b42d47cc6c24474b47251767859f188",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "ISRG's growth is fueled by robotic surgery, Ion lung biopsy and AI tools, while tariffs, product mix and softer demand pressure margins.",
                "category": "company",
                "datetime": 1784736240,
                "headline": "ISRG Trends Point to AI, Lung Biopsy Growth and Margin Pressure"
              },
              {
                "id": 140984724,
                "url": "https://finnhub.io/api/news?id=b815e8f186230069c844603013fcb9e7af4852d0d473a0021673777909f3f8df",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "ISRG's strong procedure growth, recurring revenue and cash position support its case, but tariffs, mix shifts and placement risks cloud the outlook.",
                "category": "company",
                "datetime": 1784736180,
                "headline": "Is ISRG Stock Worth Buying as Growth Stays Strong but Risks Rise"
              },
              {
                "id": 140983576,
                "url": "https://finnhub.io/api/news?id=cc56e6ed0f66a3ccedc5e3999eea4c7c34fced4b564f2e0639177abb9b833498",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1664824574/image_1664824574.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MDT",
                "summary": "Orchestra BioMed nears pivotal trial readouts for AVIM Therapy & Virtue SAB, backed by Medtronic/Terumo. Click to see catalysts, valuation & upside.",
                "category": "company",
                "datetime": 1784722005,
                "headline": "Orchestra BioMed: Nearing The First Of Two Pivotal Readouts"
              },
              {
                "id": 140983039,
                "url": "https://finnhub.io/api/news?id=3af468cbae481110ca71e4daaf0b3848b3cb86aca78ef879769dc79ed3241107",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Johnson & Johnson said on Wednesday the U.S. Food and Drug Administration had granted marketing authorization for its robotic surgery ‌device, as the healthcare conglomerate enters the soft-tissue robotic surgery market.  The decision ‌marks a key step for J&J's medtech business that had been seeking to compete in the robotic-assisted ​surgery market, currently dominated by Intuitive Surgical's da Vinci system.  Medtronic's Hugo robot was also approved last year.",
                "category": "company",
                "datetime": 1784719310,
                "headline": "J&J enters US robotic surgery market after device gets marketing authorization"
              },
              {
                "id": 140984726,
                "url": "https://finnhub.io/api/news?id=b007f8436b6a97262a650356dc317c7c77e8620d53a9fd7822da3e4e79f99ca5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "While Johnson & Johnson will go head to head with Intuitive in the U.S., analysts questioned whether its robotic surgery system will take meaningful share from the market leader.",
                "category": "company",
                "datetime": 1784717586,
                "headline": "J&J gets FDA authorization for Ottava robot, teeing up competition with Intuitive"
              },
              {
                "id": 140980354,
                "url": "https://finnhub.io/api/news?id=df9f1d697f207b91ea14cd0afee7c798e748350c7c4c4e6d36f73f53f54c76e7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (NYSE:MDT) has introduced Touch Surgery Aide, a next generation real-time AI platform designed for operating rooms. The platform supports AI driven surgical decision assistance for robotic assisted procedures. Its first live AI application, Instrument Exit Point (IEP), has received FDA clearance, signaling clinical and regulatory progress. Medtronic enters this launch with its stock at $82.35 and mixed recent performance. The shares are up 3.8% over the past week and 3.8% over the...",
                "category": "company",
                "datetime": 1784711461,
                "headline": "Medtronic (MDT) Unveils Touch Surgery Aide For Real Time AI In Operating Rooms"
              },
              {
                "id": 140977726,
                "url": "https://finnhub.io/api/news?id=9651a5589cca792b3ba10766232e4946c027a81dd101789a543466a9be76cae8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (MDT) reached $82.35 at the closing of the latest trading day, reflecting a -1.13% change compared to its last close.",
                "category": "company",
                "datetime": 1784670605,
                "headline": "Medtronic (MDT) Stock Declines While Market Improves: Some Information for Investors"
              },
              {
                "id": 140974912,
                "url": "https://finnhub.io/api/news?id=bbdead80568b813174817288369cedcdbc1558cbe69a3fa5d808987e69a9b82d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "The market is offering a steep discount on this medical device maker, but the price tag comes with a story about slowing growth. Here’s how to read it.",
                "category": "company",
                "datetime": 1784660157,
                "headline": "Why BSX Stock Hands You So Much Cash Right Now"
              },
              {
                "id": 140974913,
                "url": "https://finnhub.io/api/news?id=aa203e7f28d79433427fb12950820e559672ed5b69c0e2a20f702bef68a97fcc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "At $353, Intuitive Surgical (ISRG) is being priced to deliver 14.1% revenue growth annually for the next 4 years simply to defend today's 42.1x multiple. That sits below the 21% the business is currently growing at, which is the unusual part. The multiple has already priced in a slowdown that has not yet appeared.",
                "category": "company",
                "datetime": 1784659383,
                "headline": "ISRG Stock: The Math Hidden In Its Price"
              },
              {
                "id": 140969413,
                "url": "https://finnhub.io/api/news?id=961a0334dc44ccfb611ea4323ba249e691e72e4e5e2e277dae75441a1b2d85ac",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (NYSE: MDT), a global leader in healthcare technology, is presenting an early look at its next-generation compute platform for the operating room. Touch Surgery™ Aide — an AI-native surgical computing platform that powers the Touch Surgery™ ecosystem — enables real-time artificial intelligence during procedures. Touch Surgery™ Aide will be shared at the Society of Robotic Surgery (SRS) 2026 Annual Meeting in Florida, July 23-26.",
                "category": "company",
                "datetime": 1784631600,
                "headline": "A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026"
              },
              {
                "id": 140963421,
                "url": "https://finnhub.io/api/news?id=6ea0dd033658292f48582a592a40caa31066d357172a543dd20d199c2861cc74",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "You can be forgiven for doing a double-take on Intuitive Surgical (ISRG) on Friday. The company posted second-quarter revenue of $2.89 billion, up 19% from a year ago and comfortably ahead of Wall Street estimates. Yet the stock ended the day down 14.1%, closing at a new 52-week low.",
                "category": "company",
                "datetime": 1784574905,
                "headline": "The Robot Maker's Paradox"
              },
              {
                "id": 140963403,
                "url": "https://finnhub.io/api/news?id=f4884d142c8fe4723c200af3df0c71c73b1c873e2c314a7447d92ad950c86ede",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "The healthcare giant's pharma division is booming, but analysts on its latest call wanted to know if that's enough to cover for a sudden slowdown in MedTech.",
                "category": "company",
                "datetime": 1784573756,
                "headline": "Reading Between The Lines Of JNJ Stock's Latest Call"
              },
              {
                "id": 140963423,
                "url": "https://finnhub.io/api/news?id=26047126ae59bd8c4eb72c217ec847dd194744894cd020aa98db1bbb6da3a19e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "The surgical robotics giant beat estimates, but a moderation in its core US market has investors questioning the whole story.",
                "category": "company",
                "datetime": 1784571665,
                "headline": "What's More Important For Intuitive Surgical: Today's Robots Or Tomorrow's Growth?"
              },
              {
                "id": 140962214,
                "url": "https://finnhub.io/api/news?id=5fa01c47ee66f755ff66c19d211444017289dcf37faf29d20577f11abcb01105",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Leading CIOs and CISOs honored for leadership, innovation, and business impact. MINNEAPOLIS, July 20, 2026 (GLOBE NEWSWIRE) -- The 2026 Minnesota ORBIE Awards honored leading chief information officers (CIOs) and chief information security officers (CISOs) from Minnesota Twins, Medtronic, Sanford Health, Cirrus Aircraft, City of Saint Paul, Data Recognition Corporation, Transamerica and Medica for their exceptional leadership. Hosted by MinnesotaCIO and MinnesotaCISO, two of over 50 Inspire Lead",
                "category": "company",
                "datetime": 1784567700,
                "headline": "2026 Minnesota ORBIE Awards Recognize Minnesota’s Top Technology and Security Executives"
              },
              {
                "id": 140958770,
                "url": "https://finnhub.io/api/news?id=b059ccc9cc5ce8a6c9282abf2ebd56428803781d09b0c80c6403e7fb908459f9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, September 1, 2026, for its first quarter of fiscal year 2027, which ends on Friday, July 31, 2026.",
                "category": "company",
                "datetime": 1784545200,
                "headline": "Medtronic to announce financial results for its first quarter of fiscal year 2027"
              },
              {
                "id": 140951754,
                "url": "https://finnhub.io/api/news?id=6ba6159069d25ba45726b5c1d6ff6db30fd98807f5de1cad5c47a5f9d5cff570",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Intuitive Surgical shares fell about 10% after Q2 2026 revenue rose 19% but guidance for da Vinci procedure growth wasn't raised, pushing ISRG below its 200-week moving average.",
                "category": "company",
                "datetime": 1784376900,
                "headline": "Why Intuitive Surgical’s Strong Quarter Still Spooked Investors"
              },
              {
                "id": 140939163,
                "url": "https://finnhub.io/api/news?id=2b7e563ff687d8cc979d3783bccd33f2bf9feb60d528dbd963b372e93e4735fb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "The healthcare giant's stock jump was about more than an earnings beat, offering proof of a growth story broader and more resilient than you thought.",
                "category": "company",
                "datetime": 1784328964,
                "headline": "Abbott Just Showed Its Growth Engine Has More Than One Cylinder"
              },
              {
                "id": 140931564,
                "url": "https://finnhub.io/api/news?id=c1f3439f3f31bb5e63491154cf43bcb3dc1f5d6f47086643b3ecba50b2f29e50",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Intuitive Surgical stock falls sharply after earnings, but this analyst believes investors are missing part of the picture.",
                "category": "company",
                "datetime": 1784301540,
                "headline": "Why This Surgical Robot Stock Is Still a Buy During Its Worst Day in 4 Years"
              },
              {
                "id": 140932973,
                "url": "https://finnhub.io/api/news?id=0504e442cf7f265bb43b0e44d54c0386af3ed0aa7fd4f592d362e90177bbdfa3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "JNJ beats Q2 estimates and raises 2026 guidance, but shares fall as MedTech misses expectations. Find out what weighed on the unit and what's next.",
                "category": "company",
                "datetime": 1784298660,
                "headline": "J&J Stock Falls Despite Strong Q2 Beat & Higher 2026 View: Here's Why"
              },
              {
                "id": 140931563,
                "url": "https://finnhub.io/api/news?id=9a8cdb541c3ef9be788480458508c8b7afe3ea54b0f0964b1a39fcf2f3561dab",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "This healthcare giant is forecasting a significant acceleration, but you are being asked to look past a slowdown in its biggest growth engine and other execution hurdles.",
                "category": "company",
                "datetime": 1784290654,
                "headline": "Can Abbott Stock Deliver on Its Second-Half Growth Promise?"
              },
              {
                "id": 140934573,
                "url": "https://finnhub.io/api/news?id=ff4636b7146dfbd125893355575681ad2790e436aa27f7e2e640993f0f0632fc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic bought the pain company to expand in neuromodulation, one of its areas of strategic focus and investment.",
                "category": "company",
                "datetime": 1784289240,
                "headline": "Medtronic completes SPR Therapeutics acquisition"
              },
              {
                "id": 140930838,
                "url": "https://finnhub.io/api/news?id=1a135d3985c03c15f27f2817229afbb531c278155028de7596572fb52e06bd0c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "The new capital will enable completion of the multi-centre investigational device exemption trial, TURBO.",
                "category": "company",
                "datetime": 1784287380,
                "headline": "RapidPulse obtains funding for stroke aspiration system"
              },
              {
                "id": 140930165,
                "url": "https://finnhub.io/api/news?id=6fe459ad1a31c2103ab611f978bfeb25d7aefe2ce166d8f775aa1d8a8675b91d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (NYSE:MDT) has completed its acquisition of SPR Therapeutics. The deal adds a minimally invasive, non opioid treatment option for chronic and acute pain to Medtronic's pain therapy portfolio. For investors watching Medtronic, this move expands the company's presence in pain care beyond its existing device lineup. SPR Therapeutics focuses on peripheral nerve stimulation, a therapy that fits into a broader push across healthcare to reduce reliance on opioid medications for pain...",
                "category": "company",
                "datetime": 1784279582,
                "headline": "Medtronic (MDT) Completes SPR Therapeutics Deal To Expand Non Opioid Pain Care"
              },
              {
                "id": 140929130,
                "url": "https://finnhub.io/api/news?id=d17a9ca00e6827867f4faead149d1ad3a6253cf698cabd8781e37c5bdc1f82be",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic, a global leader in healthcare technology, and Apollo Hospitals today announced the inauguration of 'ICU of the Future' an 11-bed, state-of-the-art Intensive Care Unit (ICU) at Apollo Hospitals, Jubilee Hills. The new facility will be fully integrated with Medtronic's advanced Acute Care & Monitoring (ACM) technologies and solutions, marking a significant milestone in collaborative healthcare innovation.",
                "category": "company",
                "datetime": 1784262600,
                "headline": "Medtronic and Apollo Hospitals Announce Strategic Partnership to Establish State-of-the-Art Advanced ICU in Hyderabad"
              },
              {
                "id": 140928282,
                "url": "https://finnhub.io/api/news?id=59b1abf7332c16ef0dc2c636d71381833f2aed80f0c8396e7368a03e0d790e77",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "In May 2026, Medtronic voluntarily initiated a Class II recall of 590 Octopus 4 Tissue Stabilizer devices after discovering an assembly issue in the tubing configuration, with the US FDA now listing the action as an ongoing enforcement event affecting worldwide distribution. Around the same time, Medtronic’s fiscal Q3 2024 results exceeded earnings and revenue expectations, drawing attention to how the company balances quality-control challenges with operational and financial...",
                "category": "company",
                "datetime": 1784250696,
                "headline": "How Medtronic’s (MDT) Targeted Device Recall and Earnings Beat Have Changed Its Investment Story"
              },
              {
                "id": 140920976,
                "url": "https://finnhub.io/api/news?id=76bc23d4d790ded7e25ac854371641c9f43064d0b6f2a5978ce3830dc769912b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Abbott’s (ABT) latest financial disclosure reveals a significant strategic evolution that market participants often overlook amidst the focus on quarterly beats. The company is actively executing a structural pivot, shifting its capital allocation and growth dependency away from the volatile Nutrition segment toward high-margin, innovation-led MedTech and specialized diagnostics.",
                "category": "company",
                "datetime": 1784210345,
                "headline": "Why Abbott Stock Is Reimagining Its Future"
              },
              {
                "id": 140919685,
                "url": "https://finnhub.io/api/news?id=8aaaa1ac492f93cd7e2c8a593e3ee9b65133645f1fcce9caf8568dc8cb52f96d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "While many investors focus on a slowdown in one business segment, they may be overlooking the remarkable growth occurring in another.",
                "category": "company",
                "datetime": 1784207994,
                "headline": "The Real Engine Behind Johnson & Johnson Stock's Next Climb"
              },
              {
                "id": 140919932,
                "url": "https://finnhub.io/api/news?id=d14539e7d0d93084fd85fd25537a4c9177a39c604c11304698740004010773da",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has completed its acquisition of SPR Therapeutics, Inc. (SPR), a privately held medical technology company and recognized leader in short-term, percutaneous peripheral nerve stimulation (PNS) therapies for chronic and acute pain management. The acquisition is valued at $650 million, consisting of an upfront cash payment.",
                "category": "company",
                "datetime": 1784206800,
                "headline": "Medtronic completes acquisition of SPR, expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain"
              },
              {
                "id": 140049019,
                "url": "https://finnhub.io/api/news?id=7a629db8b449d905f61c4ffdf1b6684b342fcc22ebf1c524d64b1d845debb6ed",
                "image": "",
                "source": "Benzinga",
                "related": "MDT",
                "summary": "",
                "category": "company",
                "datetime": 1784205329,
                "headline": "Carlsmed Announces Aprevo Bi-Lateral Posterior Lumbar Interbody Fusion Procedure"
              },
              {
                "id": 140919933,
                "url": "https://finnhub.io/api/news?id=a51bf2012721df69e5fb63d419bef55076b32cdcd5158fb046ab1523fb8070c2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Round includes participation from Medtronic and top healthcare investorsMIAMI, July 16, 2026 (GLOBE NEWSWIRE) -- RapidPulse, Inc., a medical technology company developing next-generation aspiration technology for the treatment of acute ischemic stroke, today announced the close of a $48 million Series B financing. The raise, which drew substantial investor interest, was co-led by Medtronic, TechWald Next S.p.A., and S3 Ventures. SBI Investment Company Ltd. and Florida Opportunity Fund also joine",
                "category": "company",
                "datetime": 1784205000,
                "headline": "RapidPulse Secures Oversubscribed $48M Series B Financing to Advance Clinical Development of Next-Generation Stroke Aspiration Technology"
              },
              {
                "id": 140912813,
                "url": "https://finnhub.io/api/news?id=af3b9436f23bb6328aa43e6b3e1faf8d7dd198364bfa6e28cf7cd911df9289f9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Intuitive Surgical's powerful growth is running headlong into some serious market challenges, and how management framed the collision tells you everything about the real risks.",
                "category": "company",
                "datetime": 1784140381,
                "headline": "The Open Questions On ISRG Stock"
              },
              {
                "id": 140911296,
                "url": "https://finnhub.io/api/news?id=aee602b293e01bdae62f2d6674938ab67845e74bf45b3536a1bd3aa55fdad064",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Johnson & Johnson stock dipped early Wednesday, though the healthcare giant beat second-quarter forecasts and raised its outlook.",
                "category": "company",
                "datetime": 1784134793,
                "headline": "J&J Slipped On Its Report; Why It Bodes Well For Intuitive, Abbott, Others"
              },
              {
                "id": 140906349,
                "url": "https://finnhub.io/api/news?id=860fb66b88fd759276769fb8a53b2780d4b74c57e4415a03d22a898482e4c8db",
                "image": "https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp",
                "source": "ChartMill",
                "related": "MDT",
                "summary": "Medtronic (NYSE:MDT) offers a strong 3.50% dividend yield, backed by top-tier profitability and a 10-year growth history, making it a standout pick for sustainable income investors.",
                "category": "company",
                "datetime": 1784103032,
                "headline": "Medtronic PLC (NYSE:MDT): A Top Dividend Stock for Quality and Income Investors"
              },
              {
                "id": 140901598,
                "url": "https://finnhub.io/api/news?id=1c30ec9fc5eaa65b249de9077cf426329d566c616ac5f9591f0e7f9ba8098349",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Intuitive Surgical stock tumbled Tuesday after HCA Healthcare trimmed its full-year earnings outlook, noting a drop in surgeries.",
                "category": "company",
                "datetime": 1784058057,
                "headline": "Why This Group Of Medical Giants, Including Intuitive Surgical, Just Took A Tumble"
              },
              {
                "id": 140901109,
                "url": "https://finnhub.io/api/news?id=deff9c90bb7e909239d4818d05eb00911aa88c16bd160a2315a273ea8e21cb70",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "MDT",
                "summary": "Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Tuesday as we examine the latest happenings in today's session.",
                "category": "company",
                "datetime": 1784055900,
                "headline": "Discover which S&P500 stocks are making waves on Tuesday."
              },
              {
                "id": 140901466,
                "url": "https://finnhub.io/api/news?id=3b28393a5831026f9ac3732237381ea888082eee864a93bb498cf961a423a22f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Here is a way to get paid a meaningful income now on your Intuitive Surgical shares, cash you keep no matter what, in exchange for capping your gains at a price above today's.",
                "category": "company",
                "datetime": 1784052407,
                "headline": "The Paid-To-Hold Play On ISRG Stock: A 12% Income"
              },
              {
                "id": 140898964,
                "url": "https://finnhub.io/api/news?id=76a3fb9d03f8bf894bf401ec3d9d7e7a7980e4769b9be8dd004e0986d25fa30d",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "MDT",
                "summary": "Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.",
                "category": "company",
                "datetime": 1784046901,
                "headline": "These S&P500 stocks are moving in today's session"
              },
              {
                "id": 140091407,
                "url": "https://finnhub.io/api/news?id=4f3bae5f1a4e13b081552f7770afdce76cba0f5763322ce7524be732ab5f910f",
                "image": "",
                "source": "Benzinga",
                "related": "MDT",
                "summary": "",
                "category": "company",
                "datetime": 1784034450,
                "headline": "Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation"
              },
              {
                "id": 140896860,
                "url": "https://finnhub.io/api/news?id=69cac81872a917b82ac0a4526f38f4b08928a2ae81ab419989126f3ac804ca95",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "This is a product-cycle year for Intuitive Surgical. The company's growth is fueled by hospitals and surgeons adopting its new da Vinci 5 and existing Ion robotic systems.",
                "category": "company",
                "datetime": 1784033543,
                "headline": "ISRG Stock: What Does Its Valuation Imply?"
              },
              {
                "id": 140898735,
                "url": "https://finnhub.io/api/news?id=5c19ba90558b63a8e3a7afa5519de014d199a61a22aab71804f621e6b3d1ed32",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/14/2026-To-Be-Far-Worse.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MDT",
                "summary": "Investors turn to dividend-yielding stocks during market turbulence. Benzinga's Analyst Stock Ratings page provides latest analyst takes on top stocks, sorted by accuracy. Ratings for three high-yielding health care stocks: VTRS, MDT, GSK. VTRS to report Q2 results on Aug.6, MDT recalls certain catheter system, GSK reports positive trial results. Benzinga Pro's newsfeed provides real-time alerts.",
                "category": "company",
                "datetime": 1784014208,
                "headline": "Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields"
              },
              {
                "id": 140894719,
                "url": "https://finnhub.io/api/news?id=0696d9a22b1282c2f8fcc200711ba2063bff307e55a7c7e92466a4ad93a64192",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Ian Wells, former Global Chief Financial Officer of HOYA Vision Care, appointed CFO, bringing multi-billion-dollar P&L leadership and capital-markets disciplineTom West, who led Intersect ENT to its $1.1 billion acquisition by Medtronic and Nalu Medical to its $600 million acquisition by Boston Scientific, joins as an Independent Board MemberAppointments build the financial and governance foundation for ViCentra’s next phase, following the recent scale-up of commercial manufacturing UTRECHT, The",
                "category": "company",
                "datetime": 1784014200,
                "headline": "ViCentra Appoints Ian Wells as Chief Financial Officer and Adds Medtech Veteran Tom West to its Board"
              },
              {
                "id": 140894196,
                "url": "https://finnhub.io/api/news?id=ce54dcd3213fe39a575ae9d8dfca8d8c3c8ab18a053b31d59baa95ee32ca2d22",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Blood Glucose Monitoring System Market size & share revenue was valued at approximately USD 16.8 Billion in 2025 and is expected to reach USD 18.3 Billion in 2026 and is expected to reach around USD 39.4 Billion by 2035, at a CAGR of 8.9% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Insulet Corporati",
                "category": "company",
                "datetime": 1784003400,
                "headline": "Global Blood Glucose Monitoring System Market Size to Reach USD 39.4 Billion by 2035 | Growing at 8.9% CAGR | Industry Trends, Market Share & Forecast – Custom Market Insights"
              },
              {
                "id": 140890735,
                "url": "https://finnhub.io/api/news?id=7009e2dda4d96c52e7d8fb57e4f9f0e47b2235c75db4148ec6061f98f4f790bd",
                "image": "",
                "source": "Benzinga",
                "related": "MDT",
                "summary": "https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/pulmonary-valve-catheter-delivery-system-recall-medtronic-removes-harmony-delivery-catheter-system",
                "category": "company",
                "datetime": 1783955562,
                "headline": "Reported Earlier: FDA Announces Medtronic Recalls Certain Harmony Delivery Catheter System"
              },
              {
                "id": 140885956,
                "url": "https://finnhub.io/api/news?id=087b5685a9462b95788424a1d6cfb48b2ecca25fbdba085caa948b1a96b5afbe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Intuitive Surgical (NASDAQ:ISRG) looks compelling ahead of its July 16 earnings report, and the setup rarely gets this clean for a category leader trading well below fair value. Shares sit at $413.58, down 26.71% YTD, while the 247 base-case target of $559.79 implies 35.35% upside. Wall Street sits higher still at $563.35, with 22 buy ... Intuitive Surgical Has +35% Upside: A Compelling Buy Story Before July 16",
                "category": "company",
                "datetime": 1783944022,
                "headline": "Intuitive Surgical Has +35% Upside: A Compelling Buy Story Before July 16"
              },
              {
                "id": 140885071,
                "url": "https://finnhub.io/api/news?id=71b31314daf117ab4b7a113eb37cfe524f5210f5754749ce4767d53f3ef0320c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Opportunities in the nerve repair biomaterials market include advancements in regenerative medicine, rising demand for minimally invasive procedures, and smart biomaterials integration. Growth is driven by increased traumatic brain injuries, aging populations, and regional expansion, especially in Asia-Pacific. Nerve Repair Biomaterials Market Nerve Repair Biomaterials Market Dublin, July 13, 2026 (GLOBE NEWSWIRE) -- The \"Nerve Repair Biomaterials Market Report 2026\" has been added to ResearchAn",
                "category": "company",
                "datetime": 1783942080,
                "headline": "Comprehensive Nerve Repair Biomaterials Market Report Published, Profiles Medtronic, Stryker, Boston Scientific, and 20 Other Key Players"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 2,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.6,
            "source_article_count": 115,
            "discarded_article_count": 96
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 21.2,
        "grade": "良好",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 2,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 2,
            "vcp_reason": "跌縮量(近10日4日)；站上MA50；升放量(近10日2日)；收盤突破20日高位；Ready=N；Confirm=Y",
            "vcp_metrics": {
              "up_days": 4,
              "vol_ref": 7610323.333333333,
              "down_days": 5,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 7311400,
              "avg_vol_20": 7090460,
              "avg_vol_30": 7610323.333333333,
              "range_pct_10": 0.06453416843753507,
              "range_pct_20": 0.11195615702941511,
              "range_pct_30": 0.12123923498490106,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 2,
              "breakout_20d_ok": true,
              "vol_ratio_10_30": 0.9607213359747746,
              "dist_to_20d_high": -0.00483254663969423,
              "down_shrink_days": 4,
              "breakout_level_20d": 88.98,
              "vcp_breakout_confirm": true,
              "contraction_ratio_10_30": 0.5322878228782295
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.8,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.8,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.461805167207247,
              "turnoverUsdM": 587.4264717099999,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.MDT",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 85.0078,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 0.5,
              "macd_score": 3,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 4.9,
            "take_profit_price": 94.0103,
            "target_multiplier": 1.9,
            "technical_strength": 1.65,
            "take_profit_percent": 5.1
          },
          "positionPoints": 1.6,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 4.923610334414494,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 2.2011,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.46
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 130.55
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.0378
    },
    "kdj": {
      "d": 64.47,
      "j": 88.44,
      "k": 72.46,
      "rule": "Cursor_18.24 K/D cross",
      "score": 6,
      "signal": "強金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "入貨中",
      "score": 8,
      "value": 64.95
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 4,
      "trend": "弱勢",
      "value": 33697131,
      "recentSlope": -634536.9,
      "previousSlope": 3580660
    },
    "rsi": 75.58,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 80.6342,
      "position": "SAR喺價下",
      "distancePct": 9.82,
      "previousTrend": "上升"
    },
    "ma50": 81.9582,
    "macd": {
      "macd": 1.665882732717975,
      "trend": "強烈看漲",
      "signal": 1.4164390698207527,
      "histogram": 0.2494436628972223
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 84.5842,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 18
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.92,
      "score": 4,
      "avgVolume": 7174702,
      "currentVolume": 6570031
    },
    "derived": {
      "ma20": 84.519,
      "ma50": 81.9582,
      "prevClose": 87.16,
      "avgVolume10": 7426343,
      "avgVolume20": 7174702,
      "changePercent": 2.58,
      "avgVolumeForScore": 7174702
    },
    "ma_cross": {
      "ma20": 84.519,
      "ma50": 81.9582,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 84.227,
      "prevMa50": 81.6814,
      "spreadPct": 3.12,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 79.4809,
      "upper": 89.5571,
      "position": "上半部"
    },
    "rsi_short": 86.28,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.92
    }
  }
}

{
  "close": 89.41,
  "volume": 6570031,
  "changePercent": 2.58
}